生物来源
rabbit
质量水平
抗体形式
purified antibody
抗体产品类型
primary antibodies
克隆
polyclonal
表单
liquid
包含
≤0.1% sodium azide as preservative
种属反应性
human
制造商/商品名称
Calbiochem®
储存条件
do not freeze
同位素/亚型
IgG
运输
wet ice
储存温度
2-8°C
靶向翻译后修饰
unmodified
基因信息
human ... CTSD(1509)
一般描述
兔抗组织蛋白酶D(Ab-2)多克隆抗体识别乳腺癌组织中组织蛋白酶D的~52 kDa潜态(latent)形式和 ~34 kDa亚基。它经过验证可用于冷冻和石蜡切片的WB和IHC分析。
可识别乳腺癌组织提取物中组织蛋白酶D〜52 kDa的潜在形式和〜34 kDa的亚基，但不可识别〜14 kDa亚基。
纯化的兔多克隆抗体。可识别组织蛋白酶D〜52 kDa的潜在形式和〜34 kDa的（但不包括〜14 kDa）活性亚基。
免疫原
人
纯化的人肝组织蛋白酶D
应用
冷冻切片（5 µg/ml）
免疫印迹（2.5 µg/ml）
石蜡切片（5 µg/ml，需要胰蛋白酶预处理）
免疫印迹（2.5 µg/ml）
石蜡切片（5 µg/ml，需要胰蛋白酶预处理）
包装
请参考特定浓度批号的标签。
外形
溶于50 mM磷酸钠缓冲液（pH 7.5），含0.2％明胶。
分析说明
阳性对照
HT1080浓缩条件培养基或乳腺癌组织
HT1080浓缩条件培养基或乳腺癌组织
其他说明
Rochefort, H. 1992.Eur. J. Cancer28A, 1780.
Rochefort, H. 1990.In Seminars in Cancer Biology, ed. M. M. Gottesman.Vol. 1(2), 153.
Westly, B. and Rochefort, H. 1980.Cell20, 352.
Barret, A. J. 1977.In Proteinases in Mammalian Cells and Tissues, ed. Barret, A. J., North Holland, New York, p 209.
Rochefort, H. 1990.In Seminars in Cancer Biology, ed. M. M. Gottesman.Vol. 1(2), 153.
Westly, B. and Rochefort, H. 1980.Cell20, 352.
Barret, A. J. 1977.In Proteinases in Mammalian Cells and Tissues, ed. Barret, A. J., North Holland, New York, p 209.
为了获得最佳的免疫印迹结果，应在上样前将HT1080细胞的条件培养基浓缩10-20X。在单个系统中，应对抗体进行滴定以获得最佳结果。
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
免责声明
毒性：标准处理（A）
未找到合适的产品？
试试我们的产品选型工具.
储存分类代码
10-13 - German Storage Class 10 to 13
法规信息
新产品
S N Wickramasinghe et al.
British journal of haematology, 101(2), 245-250 (1998-06-03)
Ultrastructural immunocytochemical studies were performed on sections of bone marrow from three patients with beta-thalassaemia major and two patients with haemoglobin H (HbH) disease. Some sections were reacted with either a polyclonal or a monoclonal anti-human-ubiquitin antibody and the reaction
Vaishnavi Venugopalan et al.
International journal of molecular sciences, 22(11) (2021-06-03)
Cathepsin K-mediated thyroglobulin proteolysis contributes to thyroid hormone (TH) liberation, while TH transporters like Mct8 and Mct10 ensure TH release from thyroid follicles into the blood circulation. Thus, thyroid stimulating hormone (TSH) released upon TH demand binds to TSH receptors
Espen Melum et al.
Nature immunology, 20(12), 1644-1655 (2019-10-23)
Invariant natural killer T (iNKT) cells recognize activating self and microbial lipids presented by CD1d. CD1d can also bind non-activating lipids, such as sphingomyelin. We hypothesized that these serve as endogenous regulators and investigated humans and mice deficient in acid
Seung-Il Choi et al.
Autophagy, 8(12), 1782-1797 (2012-09-22)
Granular corneal dystrophy type 2 (GCD2) is an autosomal dominant disease characterized by a progressive age-dependent extracellular accumulation of transforming growth factor β-induced protein (TGFBI). Corneal fibroblasts from GCD2 patients also have progressive degenerative features, but the mechanism underlying this
Petr Vodicka et al.
Journal of Huntington's disease, 5(3), 249-260 (2016-10-01)
Mutant huntingtin (mHTT) is encoded by the Huntington's disease (HD) gene and its accumulation in the brain contributes to HD pathogenesis. Reducing mHTT levels through activation of the autophagosome-lysosomal pathway may have therapeutic benefit. Transcription factor EB (TFEB) regulates lysosome
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持